Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Novartis’ MS drug Gilenya wins Chinese approval

Novartis’ multiple sclerosis drug Gilenya won approval in China as the Swiss drugmaker expands further into the world’s most-populous country’s growing healthcare sector.

Read More »

Second opioid distributor charged over role in U.S. drug epidemic

An Ohio drug wholesale distributor and two former executives were charged with profiting from the U.S. opioid epidemic by selling millions of pills despite signs the addictive drugs were being misused.

Read More »

Exclusive: Canada warns U.S. against drug import plans, citing shortage concerns

Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country’s drug supply or raise costs for its own citizens – officials told U.S. authorities – in a new setback to the Trump administration’s efforts to tackle high drug prices, according to documents obtained by Reuters.

Read More »

Recent cannabis use tied to memory deficits, slowed mental processing

People who have recently used cannabis may be more likely to experience memory deficits or difficulties with cognitive function than those who do not use the drug, a recent study suggests.

Read More »

U.S. overdose deaths post annual drop for first time in two decades

U.S. overdose deaths dropped during 2018 for the first time in nearly two decades, the CDC said, in a sign that a nationwide epidemic of drug-related deaths is abating.

Read More »

Merck’s infections drug Recarbrio wins FDA approval

The U.S. Food and Drug Administration approved Merck & Co. Inc.’s combination treatment for complicated forms of urinary tract and abdominal infections.

Read More »

U.S. FDA says Indian drugmaker Strides Pharma Science was shredding, dumping key documents

A U.S. FDA investigator discovered that India’s Strides Pharma Science Ltd. – which exports to the U.S. market – was shredding drug production, quality and laboratory documents.

Read More »

As steep patent cliff looms, Shionogi moves to develop own U.S. sales staff

For much of the company’s 141-year history, Japan’s Shionogi & Co. Ltd. has played safe when selling drugs in the United States and other overseas markets – relying on bigger partners to promote products and avoiding the cost of maintaining a large sales force.

Read More »

Study confirms heart benefit of soy as FDA reviews this claim

U.S. regulators should continue to recommend soy protein as part of a heart-healthy diet because it helps lower cholesterol, researchers conclude from an analysis of dozens of studies done in the past two decades.

Read More »

Abbott to hike production of lower-cost glucose monitors as diabetes soars

Abbott Laboratories plans to ramp up manufacturing capacity for the company’s lower-cost continuous glucose monitor – the FreeStyle Libre – by three to five times in the next few years, aiming to reach millions more patients worldwide.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom